-
Sinovac Begins Pediatric Vaccine Trials In South Africa
Chinese vaccine makers Sinovac Biotech has launched the main phase of a global Covid vaccine study on children and teenagers in South Africa, with the first two participants jabbed in Pretoria. The study is testing the efficacy of Sinovac’s two-dose CoronaVac on 14,000 children aged between six months and 17 years in Chile, Kenya, Malaysia,…
-
3.9M COVAX: 5 States Received 29% Of AstraZeneca Vaccine
Out of the 36 states, five states received a larger share of the 3.92 million Oxford/AstraZeneca vaccine secured by the Nigerian government. Since commencement of the distribution of the AstraZeneca vaccine in Nigeria, Lagos, Kano, Abuja, Kaduna and Plateau has received a total of 1.14million doses. This, according to calculations, is about 29 percent of…
-
Covid-19: Nine Countries Suspend Use Of Oxford-AstraZeneca Vaccine
About nine countries have suspended the use of the Oxford-AstraZeneca covid-19 vaccine after reports of blood clots. The nine countries—Norway, Iceland, Austria, Estonia, Lithuania, Luxembourg, Italy, Latvia and Denmark have temporarily suspended use of the vaccine as a precautionary move after reports of blood clots and one death. The decisions are a setback for Europe’s…
-
Senior Doctors Call For A Reduction In The Gap Between Vaccine Doses
Senior doctors in the UK have called for the reduction in the gap between the first and second doses of the Pfizer coronavirus vaccine to allow for a high number of people to be vaccinated. UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) recently opted to delay a second Pfizer dose for up to 12…